Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Primary Purpose
Hemorrhoids
Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Ketamine
Sponsored by
About this trial
This is an interventional treatment trial for Hemorrhoids focused on measuring hemorrhoidectomy, ketamine, post operative pain
Eligibility Criteria
Inclusion Criteria:
- Adults aged 18-100
- Undergoing a hemorrhoidectomy for Grade III or IV hemorrhoids.
Exclusion Criteria:
- Inability to undergo general anesthesia
- Contraindications to hemorrhoidectomy
- History of schizophrenia or other hallucinatory psychiatric illnesses
- History of psychosis
- Chronic narcotic usage defined as either having a pain contract with a pain management specialist and no narcotic usage for one month prior to hemorrhoidectomy.
Sites / Locations
- OU Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intraoperative ketamine infusion
Control group
Arm Description
Subjects in this group will receive standard anesthesia during surgery and a dose of ketamine at 0.3 mg/kg IV bolus prior to surgical incision. If the procedure lasts more than 1 hour, an additional bolus dose will be given.
This group will only receive the standard anesthesia during surgery with no ketamine.
Outcomes
Primary Outcome Measures
Change in post-operative narcotic usage
Standardized pain control regimen with ketamine; at two week surgical follow-up visit patient will bring their oxycodone prescription and we will count the number of pills that were taken.
Secondary Outcome Measures
Change in post-op pain
Wong-Baker FACES Pain Rating Scale, which ranges from 0 to 10, with 0 being represented by a happy face indicating "No Hurt" to 10, represented by a crying face, indicating "hurts like the worst pain imaginable".
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04248205
Brief Title
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Official Title
Intra-operative Use of Ketamine for Post-Operative Analgesia in Patients Undergoing Hemorrhoidectomy: A Prospective, Randomized Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 15, 2020 (Actual)
Primary Completion Date
January 31, 2023 (Anticipated)
Study Completion Date
July 28, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oklahoma
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a prospective, randomized study of ketamine versus no ketamine in approximately 100 patients undergoing hemorrhoidectomy for Grade III or IV hemorrhoids. The participants will be blinded to which treatment arm they are assigned, because participants will be under anesthesia when the ketamine is administered. The investigators will know whether the participant receives ketamine or not.
Detailed Description
Participants will be randomized into 2 groups: intraoperative ketamine infusion during operation or routine anesthesia with no ketamine. Participants are pre-medicated in the operating room with the same regimen: Gabapentin 300mg, Ultram 50mg, and Tylenol 1000mg.
For participants in the ketamine group, a pain dose of ketamine 0.3mg/kg IV bolus dosing will be given prior to incision. If the procedure lasts longer than 1 hour, an additional bolus dose will be given. All participants will undergo general anesthesia and receive routine anesthesia care, aside from ketamine verus no ketamine. All participants will also receive standard local anesthesia including a local regional perianal nerve block.
The procedure will be performed by three different surgeons, with the surgery done the same way using ligasure hemorrhoidectomy. Participants will all be sent home with the same post-operative instructions and pain medications to include: Tylenol 1000mg, oxycodone 5mg, ibuprofen 800mg, fiber/miralax, and tub baths twice daily for 15 minutes.
A patient pain handout will be given to participants upon discharge with instructions to rate pain according to a numeric rating scale and the Wong-Baker FACES pain scale. Participants will be contacted by a member of the research team to assess their post-operative pain based on a numeric rating scale. All participants will undergo post-operative clinic follow-up at 2 weeks post-operation. At that time they will be instructed to bring their oxycodone bottle to assess how many pills the participant required. The clinic medical assistant will count the number of remaining pills and record this in the electronic medical record. If a participant forgets their pain scale record or medications, a post-operative phone interview will be performed after the clinic appointment to gather this information.
The investigators will randomize 50 participants to the ketamine group and 50 participants to the placebo group. Study will take place until all participants have been analyzed, approximately 8-12 months. Randomization will occur using a statistical method with study arms placed into individual envelopes that will be stored at the University of Oklahoma (OU) Surgery Center. The investigator will blindly pull an envelope from the stack which will identify the participant's treatment arm. The participants will be blinded and not informed of their arm of the study as to not create bias toward subjective pain. Practitioners will not be blinded for ease of medication administration. The procedures will occur at OU Surgery Center by one of three surgeons. Anesthesiologists will administer ketamine based on study arm.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemorrhoids
Keywords
hemorrhoidectomy, ketamine, post operative pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intraoperative ketamine infusion
Arm Type
Active Comparator
Arm Description
Subjects in this group will receive standard anesthesia during surgery and a dose of ketamine at 0.3 mg/kg IV bolus prior to surgical incision. If the procedure lasts more than 1 hour, an additional bolus dose will be given.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
This group will only receive the standard anesthesia during surgery with no ketamine.
Intervention Type
Drug
Intervention Name(s)
Ketamine
Intervention Description
Standard general anesthesia PLUS ketamine will be given for post-operative analgesia
Primary Outcome Measure Information:
Title
Change in post-operative narcotic usage
Description
Standardized pain control regimen with ketamine; at two week surgical follow-up visit patient will bring their oxycodone prescription and we will count the number of pills that were taken.
Time Frame
two weeks post-operation
Secondary Outcome Measure Information:
Title
Change in post-op pain
Description
Wong-Baker FACES Pain Rating Scale, which ranges from 0 to 10, with 0 being represented by a happy face indicating "No Hurt" to 10, represented by a crying face, indicating "hurts like the worst pain imaginable".
Time Frame
Post-op days 1, 3, 5, 7, and 10
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults aged 18-100
Undergoing a hemorrhoidectomy for Grade III or IV hemorrhoids.
Exclusion Criteria:
Inability to undergo general anesthesia
Contraindications to hemorrhoidectomy
History of schizophrenia or other hallucinatory psychiatric illnesses
History of psychosis
Chronic narcotic usage defined as either having a pain contract with a pain management specialist and no narcotic usage for one month prior to hemorrhoidectomy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Steven N Carter, MD
Phone
405-271-8001
Ext
55000
Email
steven-carter@ouhsc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Theresa J Lander
Phone
405271-8001
Ext
43230
Email
theresa-lander@ouhsc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven N Carter, MD
Organizational Affiliation
University of Oklahoma
Official's Role
Principal Investigator
Facility Information:
Facility Name
OU Medical Center
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Principal Investigator
Phone
405-271-8001
Ext
55000
Email
steven-carter@ouhsc.edu
First Name & Middle Initial & Last Name & Degree
Study Coordinator
Phone
405-271-8001
Ext
43230
Email
theresa-lander@ouhsc.edu
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
15618805
Citation
Himmelseher S, Durieux ME. Ketamine for perioperative pain management. Anesthesiology. 2005 Jan;102(1):211-20. doi: 10.1097/00000542-200501000-00030. No abstract available.
Results Reference
background
PubMed Identifier
27275042
Citation
Gorlin AW, Rosenfeld DM, Ramakrishna H. Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):160-7. doi: 10.4103/0970-9185.182085.
Results Reference
background
PubMed Identifier
29062346
Citation
Luggya TS, Roche T, Ssemogerere L, Kintu A, Kasumba JM, Kwizera A, Tindimwebwa JV. Effect of low-dose ketamine on post-operative serum IL-6 production among elective surgical patients: a randomized clinical trial. Afr Health Sci. 2017 Jun;17(2):500-507. doi: 10.4314/ahs.v17i2.25.
Results Reference
background
Learn more about this trial
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
We'll reach out to this number within 24 hrs